Global Adjuvant Therapy Market Research Report 2023

Report ID: 1891879 | Published Date: Oct 2024 | No. of Page: 85 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Adjuvant Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Chemotherapy
        1.2.3 Radiotherapy
        1.2.4 Hormonotherapy
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Adjuvant Therapy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Medical Institution
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Adjuvant Therapy Market Perspective (2017-2028)
    2.2 Adjuvant Therapy Growth Trends by Region
        2.2.1 Adjuvant Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Adjuvant Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Adjuvant Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Adjuvant Therapy Market Dynamics
        2.3.1 Adjuvant Therapy Industry Trends
        2.3.2 Adjuvant Therapy Market Drivers
        2.3.3 Adjuvant Therapy Market Challenges
        2.3.4 Adjuvant Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Adjuvant Therapy Players by Revenue
        3.1.1 Global Top Adjuvant Therapy Players by Revenue (2017-2022)
        3.1.2 Global Adjuvant Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Adjuvant Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Adjuvant Therapy Revenue
    3.4 Global Adjuvant Therapy Market Concentration Ratio
        3.4.1 Global Adjuvant Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Adjuvant Therapy Revenue in 2021
    3.5 Adjuvant Therapy Key Players Head office and Area Served
    3.6 Key Players Adjuvant Therapy Product Solution and Service
    3.7 Date of Enter into Adjuvant Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Adjuvant Therapy Breakdown Data by Type
    4.1 Global Adjuvant Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Adjuvant Therapy Forecasted Market Size by Type (2023-2028)
5 Adjuvant Therapy Breakdown Data by Application
    5.1 Global Adjuvant Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Adjuvant Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Adjuvant Therapy Market Size (2017-2028)
    6.2 North America Adjuvant Therapy Market Size by Country (2017-2022)
    6.3 North America Adjuvant Therapy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Adjuvant Therapy Market Size (2017-2028)
    7.2 Europe Adjuvant Therapy Market Size by Country (2017-2022)
    7.3 Europe Adjuvant Therapy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Adjuvant Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Adjuvant Therapy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Adjuvant Therapy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Adjuvant Therapy Market Size (2017-2028)
    9.2 Latin America Adjuvant Therapy Market Size by Country (2017-2022)
    9.3 Latin America Adjuvant Therapy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Adjuvant Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Adjuvant Therapy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Adjuvant Therapy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Adjuvant Therapy Introduction
        11.1.4 Merck Revenue in Adjuvant Therapy Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 Bayer
        11.2.1 Bayer Company Detail
        11.2.2 Bayer Business Overview
        11.2.3 Bayer Adjuvant Therapy Introduction
        11.2.4 Bayer Revenue in Adjuvant Therapy Business (2017-2022)
        11.2.5 Bayer Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Detail
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Adjuvant Therapy Introduction
        11.3.4 Johnson & Johnson Revenue in Adjuvant Therapy Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Development
    11.4 AstraZenca
        11.4.1 AstraZenca Company Detail
        11.4.2 AstraZenca Business Overview
        11.4.3 AstraZenca Adjuvant Therapy Introduction
        11.4.4 AstraZenca Revenue in Adjuvant Therapy Business (2017-2022)
        11.4.5 AstraZenca Recent Development
    11.5 Mylan
        11.5.1 Mylan Company Detail
        11.5.2 Mylan Business Overview
        11.5.3 Mylan Adjuvant Therapy Introduction
        11.5.4 Mylan Revenue in Adjuvant Therapy Business (2017-2022)
        11.5.5 Mylan Recent Development
    11.6 AbbVie
        11.6.1 AbbVie Company Detail
        11.6.2 AbbVie Business Overview
        11.6.3 AbbVie Adjuvant Therapy Introduction
        11.6.4 AbbVie Revenue in Adjuvant Therapy Business (2017-2022)
        11.6.5 AbbVie Recent Development
    11.7 Novartis
        11.7.1 Novartis Company Detail
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Adjuvant Therapy Introduction
        11.7.4 Novartis Revenue in Adjuvant Therapy Business (2017-2022)
        11.7.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Adjuvant Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Radiotherapy
    Table 4. Key Players of Hormonotherapy
    Table 5. Key Players of Others
    Table 6. Global Adjuvant Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Adjuvant Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Adjuvant Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Adjuvant Therapy Market Share by Region (2017-2022)
    Table 10. Global Adjuvant Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Adjuvant Therapy Market Share by Region (2023-2028)
    Table 12. Adjuvant Therapy Market Trends
    Table 13. Adjuvant Therapy Market Drivers
    Table 14. Adjuvant Therapy Market Challenges
    Table 15. Adjuvant Therapy Market Restraints
    Table 16. Global Adjuvant Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Adjuvant Therapy Market Share by Players (2017-2022)
    Table 18. Global Top Adjuvant Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvant Therapy as of 2021)
    Table 19. Ranking of Global Top Adjuvant Therapy Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Adjuvant Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Adjuvant Therapy Product Solution and Service
    Table 23. Date of Enter into Adjuvant Therapy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Adjuvant Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Adjuvant Therapy Revenue Market Share by Type (2017-2022)
    Table 27. Global Adjuvant Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Adjuvant Therapy Revenue Market Share by Type (2023-2028)
    Table 29. Global Adjuvant Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Adjuvant Therapy Revenue Market Share by Application (2017-2022)
    Table 31. Global Adjuvant Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Adjuvant Therapy Revenue Market Share by Application (2023-2028)
    Table 33. North America Adjuvant Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Adjuvant Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Adjuvant Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Adjuvant Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Adjuvant Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Adjuvant Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Adjuvant Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Adjuvant Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Adjuvant Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Adjuvant Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Merck Company Detail
    Table 44. Merck Business Overview
    Table 45. Merck Adjuvant Therapy Product
    Table 46. Merck Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million)
    Table 47. Merck Recent Development
    Table 48. Bayer Company Detail
    Table 49. Bayer Business Overview
    Table 50. Bayer Adjuvant Therapy Product
    Table 51. Bayer Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million)
    Table 52. Bayer Recent Development
    Table 53. Johnson & Johnson Company Detail
    Table 54. Johnson & Johnson Business Overview
    Table 55. Johnson & Johnson Adjuvant Therapy Product
    Table 56. Johnson & Johnson Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million)
    Table 57. Johnson & Johnson Recent Development
    Table 58. AstraZenca Company Detail
    Table 59. AstraZenca Business Overview
    Table 60. AstraZenca Adjuvant Therapy Product
    Table 61. AstraZenca Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million)
    Table 62. AstraZenca Recent Development
    Table 63. Mylan Company Detail
    Table 64. Mylan Business Overview
    Table 65. Mylan Adjuvant Therapy Product
    Table 66. Mylan Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million)
    Table 67. Mylan Recent Development
    Table 68. AbbVie Company Detail
    Table 69. AbbVie Business Overview
    Table 70. AbbVie Adjuvant Therapy Product
    Table 71. AbbVie Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million)
    Table 72. AbbVie Recent Development
    Table 73. Novartis Company Detail
    Table 74. Novartis Business Overview
    Table 75. Novartis Adjuvant Therapy Product
    Table 76. Novartis Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million)
    Table 77. Novartis Recent Development
    Table 78. Research Programs/Design for This Report
    Table 79. Key Data Information from Secondary Sources
    Table 80. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Adjuvant Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Chemotherapy Features
    Figure 3. Radiotherapy Features
    Figure 4. Hormonotherapy Features
    Figure 5. Others Features
    Figure 6. Global Adjuvant Therapy Market Share by Application in 2021 & 2028
    Figure 7. Hospital Case Studies
    Figure 8. Medical Institution Case Studies
    Figure 9. Others Case Studies
    Figure 10. Adjuvant Therapy Report Years Considered
    Figure 11. Global Adjuvant Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Adjuvant Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Adjuvant Therapy Market Share by Region: 2021 VS 2028
    Figure 14. Global Adjuvant Therapy Market Share by Players in 2021
    Figure 15. Global Top Adjuvant Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvant Therapy as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Adjuvant Therapy Revenue in 2021
    Figure 17. North America Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Adjuvant Therapy Market Share by Country (2017-2028)
    Figure 19. United States Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Adjuvant Therapy Market Share by Country (2017-2028)
    Figure 23. Germany Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Adjuvant Therapy Market Share by Region (2017-2028)
    Figure 31. China Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Adjuvant Therapy Market Share by Country (2017-2028)
    Figure 39. Mexico Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Adjuvant Therapy Market Share by Country (2017-2028)
    Figure 43. Turkey Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Merck Revenue Growth Rate in Adjuvant Therapy Business (2017-2022)
    Figure 46. Bayer Revenue Growth Rate in Adjuvant Therapy Business (2017-2022)
    Figure 47. Johnson & Johnson Revenue Growth Rate in Adjuvant Therapy Business (2017-2022)
    Figure 48. AstraZenca Revenue Growth Rate in Adjuvant Therapy Business (2017-2022)
    Figure 49. Mylan Revenue Growth Rate in Adjuvant Therapy Business (2017-2022)
    Figure 50. AbbVie Revenue Growth Rate in Adjuvant Therapy Business (2017-2022)
    Figure 51. Novartis Revenue Growth Rate in Adjuvant Therapy Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Bayer
Johnson & Johnson
AstraZenca
Mylan
AbbVie
Novartis
Frequently Asked Questions
Adjuvant Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Adjuvant Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Adjuvant Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Tinea Corporis Drugs

Tinea Corporis Drugs market is segmented by players, region (country), by Type and by Application ... Read More